Randomized Double-Blind Controlled Clinical Trial
Completed · Not applicable
Conditions studied: Chronic Wounds, Acute Wounds
In brief
The study is a randomized double-blind controlled clinical trial designed to compare the ability of NaOCl to NSS in the reduction of bacterial burden in nonhealing acute and chronic wounds.
Key facts
- Study ID
- NCT04320628
- Run by
- SerenaGroup, Inc.
- People needed
- 25
- Starts
- 2020-05-20
- Expected to finish
- 2022-03-01
- Last updated by the study team
- 2022-03-14
Who can join
Age: 18 and older, up to 100. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Adult patients with acute or chronic wounds that have been present for a minimum of 4 weeks.
- A signed and dated informed consent form.
- Subject is willing and able to comply with instructions and scheduled visits.
You may not qualify if…
- The Subject has other concurrent conditions that in the opinion of the Investigator may compromise subject safety.
- The subject's wound has not been present for at least 4 weeks.
Where it is running
- Serena Group Research Institute — Pittsburgh, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.